18F-FDG PET/CT

You have access
Immune Checkpoint Inhibitor–Related Adverse Effects and ¹⁸F-FDG PET/CT Findings
Jan-Henning Schierz, Ismet Sarikaya, Uwe Wollina, Leonore Unger and Ali Sarikaya

Journal of Nuclear Medicine Technology December 1, 2021, 49 (4) 324-329; DOI: https://doi.org/10.2967/jnmt.121.262151
Open Access
Effect of COVID-19 on ¹⁸F-FDG PET/CT: Is There a Need to Consider COVID-19 Status Before Planning ¹⁸F-FDG PET/CT for Oncologic Evaluation?
Anwin Joseph Kavanal, Santosh Ranjan Jena, Rajender Kumar, Chandan Krushna Das, Sunil Kumar and Bhagwant Rai Mittal

Journal of Nuclear Medicine Technology September 1, 2021, 49 (3) 284-285; DOI: https://doi.org/10.2967/jnmt.121.262145
You have access
Poorly Differentiated Neuroendocrine Carcinoma of the Parotid Gland and Moderately Differentiated Hepatic Metastases: A Discordant Histopathology Clarified by Dual-Tracer PET/CT
Priyanka Sharma and Sandip Basu

Journal of Nuclear Medicine Technology March 1, 2021, 49 (1) 86-88; DOI: https://doi.org/10.2967/jnmt.120.251587
You have access
Cancer Patient Experience in a Nuclear Medicine Department: Comparison Between Bone Scintigraphy and ¹⁸F-FDG PET/CT
Ana M. Grilo, Lina Vieira, Elisabete Carolino, Melissa Costa, Salomé Galaio, Inês Melo, Ana Geão, Andrea Santos and Paula Colarinha

Journal of Nuclear Medicine Technology September 1, 2020, 48 (3) 254-262; DOI: https://doi.org/10.2967/jnmt.119.239285
You have access
Combined ¹⁷⁷Lu-DOTATATE Peptide Receptor Radionuclide Therapy and Platinum-Based Chemotherapy in Recurrent, Metastatic Sinonasal Neuroendocrine Carcinoma: A Promising Therapeutic Option
Aadil Adnan and Sandip Basu

Journal of Nuclear Medicine Technology September 1, 2020, 48 (3) 292-294; DOI: https://doi.org/10.2967/jnmt.119.237354
You have access
Comparison of Dual-Tracer PET and CT Features to Conventional Risk Categories in Assessing Response to ¹⁷⁷Lu-PSMA-617 Therapy for Metastatic Prostate Adenocarcinoma with Urinary Bladder Involvement
Aadil Adnan and Sandip Basu

Journal of Nuclear Medicine Technology June 1, 2020, 48 (2) 148-153; DOI: https://doi.org/10.2967/jnmt.119.235960
You have access
Validation of a Multifocal Segmentation Method for Measuring Metabolic Tumor Volume in Hodgkin Lymphoma
Mariana R. Camacho, Elba Etchebehere, Natalia Tardelli, Marcia T. Delamain, Aline F.A. Vercosa, Maria E.S. Takahashi, Sergio Q. Brunetto, Irene G.H.L. Metze, Cármino A. Souza, Juliano J. Cerci and Celso D. Ramos

Journal of Nuclear Medicine Technology March 1, 2020, 48 (1) 30-35; DOI: https://doi.org/10.2967/jnmt.119.231118
You have access
A Rare Case of Giant Intraperitoneal Lipoma Found Incidentally on ¹⁸F-FDG PET/CT in a Patient with Nodular Fasciitis
María J. Ibáñez, Rafael H. Reyes, Laura Frutos and María A. Claver

Journal of Nuclear Medicine Technology June 1, 2019, 47 (2) 173-174; DOI: https://doi.org/10.2967/jnmt.118.220152
You have access
Randomized Controlled Trial Examining Effects of Web-Based Information on Patient Satisfaction and Image Quality in ¹⁸F-FDG PET/CT Examinations
Camilla Andersson, Carlos Trampal Pulido, Håkan Ahlström and Birgitta Johansson

Journal of Nuclear Medicine Technology March 1, 2019, 47 (1) 39-46; DOI: https://doi.org/10.2967/jnmt.118.213116
You have access
Small Cell Transformation of Metastatic Prostate Adenocarcinoma Diagnosed by Dual-Tracer PET/CT (⁶⁸Ga-PSMA and ¹⁸F-FDG): Potential Clinical Utility in Therapeutic Decision Making and Treatment Monitoring
Rahul Parghane and Sandip Basu

Journal of Nuclear Medicine Technology March 1, 2019, 47 (1) 85-87; DOI: https://doi.org/10.2967/jnmt.118.215582

Main menu

User menu

Search

18F-FDG PET/CT

Pages